Garth Virgin

Safety and Immunogenicity of Modified Vaccinia Ankara-Bavarian Nordic Smallpox Vaccine in Vaccinia-Naive and Experienced Human Immunodeficiency Virus-Infected Individuals: An Open-Label, Controlled Clinical Phase II Trial

Edgar T. Overton, Jack T. Stapleton, Ian Frank et al. · Open Forum Infectious Diseases · 2015 · 142 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

Safety, Immunogenicity, and Surrogate Markers of Clinical Efficacy for Modified Vaccinia Ankara as a Smallpox Vaccine in HIV-Infected Subjects

Richard N. Greenberg, Edgar T. Overton, David W. Haas et al. · The Journal of Infectious Diseases · 2012 · 134 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

A Multicenter, Open-Label, Controlled Phase II Study to Evaluate Safety and Immunogenicity of MVA Smallpox Vaccine (IMVAMUNE) in 18–40 Year Old Subjects with Diagnosed Atopic Dermatitis

Richard N. Greenberg, Yadira Hurley, Dinh V. Dinh et al. · PLoS ONE · 2015 · 114 citations · Full text

Veterinary Medicine, Dermatology, Immunology +17

A Randomized, Double-Blind, Placebo-Controlled Phase II Trial Investigating the Safety and Immunogenicity of Modified Vaccinia Ankara Smallpox Vaccine (MVA-BN®) in 56-80-Year-Old Subjects

Richard N. Greenberg, Christine M. Hay, Jack T. Stapleton et al. · PLoS ONE · 2016 · 81 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases

Martin W. Laaß, Simon Straub, Suki Chainey et al. · BMC Gastroenterology · 2014 · 68 citations · Full text

Medicine, Pediatrics, Pharmacotherapy +17